James Siano, PhD, MBA
Country Medical Lead (Interim), Medical Affairs
Prior to joining Merck, James held various organizational leadership roles across the product development continuum at UCB Biosciences and Novartis Pharmaceuticals, including Field Medical Affairs, Global Clinical Development & Medical Affairs, Global Regulatory Affairs, and Commercial.
James began his professional career as a management consultant at Accenture, where he partnered with clients across diverse industries to realize value opportunities. James holds both a masters and doctorate in chemical and biomedical engineering from the Georgia Institute of Technology, and an international MBA from Arizona State University.
About Organon
Organon is a global health care company formed through a spin-off from Merck (NYSE: MRK), known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investment in innovation and future growth opportunities in women’s health. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast-growing international markets.
Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,500 employees with headquarters located in Jersey City, New Jersey.
For more information, connect with us on LinkedIn and Twitter.